Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

CVR Medical Corp V.CVM.H

Alternate Symbol(s):  CRRVF

Healthcare Medical Devices
CVR Medical Corp. is a medical technology organization. The Company is focused on the development and advancement of technology at work within the healthcare sector. The Company’s Carotid Stenotic Scan (CSS) is a diagnostic tool designed to detect and determine a level of carotid narrowing for the purpose of identifying patients at risk for Ischemic Stroke. The CSS provides a synergistic tool, which complements other stroke screening technology such as Duplex Doppler ultrasound (DUS), magnetic resonance angiography (MRA) and computed tomography angiography (CTA). The CSS is non-invasive and does not require the use of harmful dyes. It offers its product to patients, payers, and healthcare providers.


TSXV:CVM.H - Post by User

CVR Medical Corp > Observations
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(10)
•••
Comment by Looneytuneson Jun 02, 2021 11:46am
100 Views
Post# 33310879

RE:Observations

RE:ObservationsSo I guess we should expect an announement soon else the company will be in breach of the TSX-V condition as I assume they no longer have a CEO. I guess they'll just give it back to Blunden as no other fool would take it on now.

Paul Blunden, M.D. was hired as the interim CEO and CFO as of the resignation of Dallas Hack, M.D. The TSX-V required CVR Medical Corp. to have a CEO and CFO in place to meet the requirements of the exchange. In January 2021, the Company appointed Michael Rhodes to replace Paul Blunden, M.D. as the CEO of the Company. Paul Blunded, M.D. remains as the CFO of the Company.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities